Organon & Co. (OGN)
7.525
+0.06
(+0.87%)
USD |
NYSE |
Feb 19, 16:00
7.49
-0.04
(-0.47%)
After-Hours: 20:00
Organon Market Cap : 1.956B for Feb. 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 302.45B |
| Amphastar Pharmaceuticals, Inc. | 1.311B |
| Geron Corp. | 1.229B |
| Regeneron Pharmaceuticals, Inc. | 82.71B |
| Vertex Pharmaceuticals, Inc. | 119.19B |
Market Cap Related Metrics
| PE Ratio | 10.50 |
| PS Ratio | 0.3153 |
| Price to Book Value | 2.159 |
| Price | 7.525 |
| Earnings Yield | 9.52% |
| Operating PE Ratio | 1.599 |
| Normalized PE Ratio | 4.168 |